Change in Bordetella pertussis serology
|Download:||Change in Pertussis serology testing (Microsoft Word Document - 40k)|
Change in Chlamydia SP Antibody Testing
Chlamydia SP Antibody Testing will change from a species-specific Chlamydophilia pneumoniae to a group Chlamydia sp antibody test.
|Download:||Change in Chlamydia SP Antibody Testing (PDF File - 17k)|
ECG Testing at the Lyneham Collection Centre
ACT Pathology is now offering an ECG service at our Lyneham Collection Centre. This service features a fast turn-around of results, and bulk-billing for all Medicare-eligible patients.Please phone the Lyneham Collection Centre on 6262 7522 to make an appointment.
ACT Pathology also performs ECG testing at Gungahlin, Calvary, John James and Tuggeranong Collection Centres.
Attention: A change in patient values for Red Cell Folate
On 01/05/2011, ACT Pathology are about to introduce a more reliable and accurate method in measuring Red Cell Folate and the consequence of this will be lower values seen in your patient results by a factor of about 50%. This will also be accompanied by a small change in the reference range. When the change occurs the following comment will appear on the reports.
“PLEASE NOTE: As of 01/05/2011, a new method for RED CELL FOLATE measurement is in use. This will result in a negative shift in values of approx. 50% from the previous methodology. Interpret serial values with care.”
Please feel free to contact the laboratory on 6244 2842 if you have any concerns or queries.
New Charnwood Collection Centre
ACT Pathology’s new collection centre at Charnwood is now open, and ready to serve the residents of West Belconnen. This collection centre is located at 20 Cartwright Street, Charnwood, and has direct access from the West Belconnen Health Cooperative car park. The Charnwood Collection Centre will be open Monday to Friday; 8.00am to 4.15pm (closed from 12pm to 1pm).
Fine Needle Aspiration Service
A Fine Needle Aspiration service is available at The Canberra Hospital collection centre, by appointment.
For information regarding Fine Needle Aspiration
|Download:||FNA Service (PDF File - 156k)|
Glucose Tolerance Testing at ACT Pathology Collection Centres
Appointments are required for Glucose Tolerance Testing, and phone numbers for all collection centres are on the reverse of our Pathology Request Forms.
Influenza Testing at ACT Pathology 2010
For information regarding the latest influenza testing for the 2010 season.
|Download:||Influenza Testing at ACT Pathology 2010 (Microsoft Word Document - 51k)|
Testing of sputum for Mycobacterium tuberculosis
|Download:||Testing of sputum for Mycobacterium tuberculosis (Microsoft Word Document - 41k)|
ACT Pathology is "Child-Friendly"
We are proud to announce that Pathology Outpatients has been awarded "The most child friendly workplace at The Canberra Hospital". This award was given in association with National Child Protection Week 2005 and was presented by the President of the NAPCAN Foundation, Dr Sue Packer. The ACT Pathology collection staff have extensive training and experience in performing venepuncture on babies and children, and every one of our collections centre are "child-friendly".
New platform for testing HLA-B27 at ACT Pathology
From May 2008, ACT Pathology will introduce a new and more accurate method for testing HLA-B27. Human leukocyte antigens (HLA) are key components of the immune system.
The HLA genes are very polymorphic, that is, they vary considerably from individual to individual. Particular HLA genes confer susceptibility to immune-mediated diseases. Among the strongest associations are those between HLA-B27 and seronegative arthritides, such as ankylosing spondylitis and Reiter's syndrome. HLA-B27 is also associated with uveitis, aortitis, and colitis. Identifying individuals with the HLA-B27 gene is therefore sometimes useful.
Until now, this test has been performed by checking for expression of the gene on circulating blood cells. This method can result in both false positive and false negative results because there are significant similarities between HLA-B27 proteins and several other HLA-B proteins.
We have now introduced HLA-B genotyping, which is precise and specific. This genetic test requires a blood sample (just like the old test-EDTA-pink top). From now on, requests for HLA-B27 will be reported as HLA-B genotypes. If you would like to discuss this test further, please contact Dr Matthew Cook, Director of Immunology, (02) 6244 2929.
Change to the reporting of Oral Glucose Tolerance Tests
When reporting the results of an OGTT, ACT Pathology and many other Australian pathology laboratories, have been reporting fasting glucose concentrations between 5.6 and 6.9 mmol/L as impaired fasting glycemia.
There is some disagreement between international bodies as to whether these cutpoints are appropriate. The American Diabetes Association continues to use these cutpoints but the Australian Diabetes Society has recently recommended that we report only glucose results between 6.1 and 6.9 as impaired glucose tolerance (Twigg SM et al. Med J Aust 2007; 186: 461-465). However, it is recommended that any patient with a fasting glucose between 5.6 and 6.1 proceed to an oral GTT.
ACT Pathology will be observing this recommended reporting procedure effective immediately.If you would like to discuss this further, please contact Assoc Prof Peter Hickman, Director of Chemical Pathology, 6244 2840